News

Chiltern said that SAFE is a complete electronic Trial Master File (TMF) solution which facilitates remote management of documents, which saves administrative time and increases accuracy and security

The acquisition is likely to enhance ITT’s Analytics business, formed earlier this year with the acquisition of Nova Analytics. ITT Analytics is a manufacturer of field, portable, laboratory

Under the terms of the collaboration, which is supported by a grant from the UK East Midlands Development Agency, London Genetics and Astrimmune will put together a proposal

Potelligent Technology involves the reduction of the amount of fucose in the carbohydrate structure of an antibody using a proprietary fucosyltransferase-knockout Chinese Hamster Ovary (CHO) cell line as

ARYx‘s loss from operations was $2.15m, compared to $7.63m for the comparable period in 2009. For the nine months ended 30 September 2010 ARYx posted a net loss

According to AP Pharma, the net loss was higher in the current fiscal quarter primarily due to $1m of income recognised in the prior year quarter in connection

Zyngenia is a privately held biotherapeutics company focused on the development of next-generation multi-specific antibody-based therapeutics. Selexis co-founder and CEO Igor Fisch said that they are excited to

Pro-Pharmaceuticals’ operating loss was $1.21m, compared to $1.25m for the comparable period in 2009. For the nine months ended 30 September 2010 Pro-Pharmaceuticals posted a net loss of

According to Inovio Pharmaceuticals, the decrease in the respective periods were mainly due to no revenue being recognised under the terminated Wyeth collaboration and licensing agreement as a